These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 1999873)
1. AIDS vaccines inch closer to useful existence. Goldsmith MF JAMA; 1991 Mar; 265(11):1356-7. PubMed ID: 1999873 [No Abstract] [Full Text] [Related]
2. Development of new vaccines for AIDS. Garrison L; Clements ML Compr Ther; 1989 Jul; 15(7):47-55. PubMed ID: 2670404 [No Abstract] [Full Text] [Related]
3. Prospects for an AIDS vaccine. Girard M Cancer Detect Prev; 1990; 14(3):411-3. PubMed ID: 2117487 [TBL] [Abstract][Full Text] [Related]
4. Human trials go-ahead for the AIDS vaccine with a difference. Newmark P Nature; 1988 Apr; 332(6167):770. PubMed ID: 3282175 [No Abstract] [Full Text] [Related]
5. Human trials of experimental AIDS vaccines: recombinant envelope proteins. Snart RS AIDS; 1988; 2 Suppl 1():S107-11. PubMed ID: 2906544 [No Abstract] [Full Text] [Related]
6. Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress. Schild GC; Minor PD Lancet; 1990 May; 335(8697):1081-4. PubMed ID: 1970381 [No Abstract] [Full Text] [Related]
7. Phase I trial of potential AIDS vaccine commences. Oncology (Williston Park); 1991 May; 5(5):182. PubMed ID: 1832002 [No Abstract] [Full Text] [Related]
9. Challenges and strategies for AIDS vaccine development. Oxford JS; Frezza P; Race E Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664 [TBL] [Abstract][Full Text] [Related]
10. AIDS vaccine therapy: phase I trial. Picard O; Giral P; Defer MC; Fouchard M; Morel M; Meyohas MC; Lebas J; Imbert JC; Frottier J; Salaun JJ Lancet; 1990 Jul; 336(8708):179. PubMed ID: 1973493 [No Abstract] [Full Text] [Related]
11. Towards a vaccine against AIDS: lessons from simian immunodeficiency virus vaccines. Stott EJ Curr Top Microbiol Immunol; 1994; 188():221-37. PubMed ID: 7924428 [No Abstract] [Full Text] [Related]
12. AIDS/HIV. A STEP into darkness or light? Moore JP; Klasse PJ; Dolan MJ; Ahuja SK Science; 2008 May; 320(5877):753-5. PubMed ID: 18467578 [No Abstract] [Full Text] [Related]
13. Hepatitis B and AIDS and the promise for their control by vaccines. Hilleman MR Vaccine; 1988 Apr; 6(2):175-9. PubMed ID: 3291455 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens. Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397 [TBL] [Abstract][Full Text] [Related]
16. [Enzyme immunoassay using recombinant env peptides of human immunodeficiency virus type 1 (HIV-1) as a confirmatory technic for anti-HIV-1]. Corzo JE; Pineda JA; Rey C; Leal M Med Clin (Barc); 1989 Feb; 92(7):278-9. PubMed ID: 2654511 [No Abstract] [Full Text] [Related]
17. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children. Borkowsky W; Krasinski K; Moore T; Papaevangelou V AIDS Res Hum Retroviruses; 1990 May; 6(5):673-8. PubMed ID: 2113821 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees. Natuk RJ; Lubeck MD; Chanda PK; Chengalvala M; Wade MS; Murthy SC; Wilhelm J; Vernon SK; Dheer SK; Mizutani S AIDS Res Hum Retroviruses; 1993 May; 9(5):395-404. PubMed ID: 8318268 [TBL] [Abstract][Full Text] [Related]